Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma

Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma

Objective(s): To investigate the efficacy of pembrolizumab plus lenvatinib as a second-line or later-line therapy in women with advanced or recurrent uterine carcinosarcoma (UCS). Methods: A single-institution pharmacy database was queried for women with advanced or recurrent UCS who were prescribed...

Full description

Saved in:
Bibliographic Details
Main Authors: Jonathan T. Hunt (Author), Laura M. Chambers (Author), Meng Yao (Author), Amy Joehlin-Price (Author), Robert Debernardo (Author), Peter G. Rose (Author)
Format: Book
Published: Elsevier, 2021-08-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items